Modeling early haematologic adverse events in conformal and intensity-modulated pelvic radiotherapy in anal cancer

BACKGROUND AND PURPOSE: To determine if there are differences between dose to pelvic bone marrow (PBM) using intensity modulated radiotherapy (IMRT) under UK guidance versus conformal radiotherapy (CRT) per ACT II protocol and if differences translate to rates of early haematological adverse events...

Descripción completa

Detalles Bibliográficos
Autores principales: Robinson, Maxwell, Sabbagh, Ahmed, Muirhead, Rebecca, Durrant, Lisa, Van den Heuvel, Frank, Hawkins, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Scientific Publishers 2015
Materias:
Anal Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678285/
https://www.ncbi.nlm.nih.gov/pubmed/26409831
http://dx.doi.org/10.1016/j.radonc.2015.09.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678285/
https://www.ncbi.nlm.nih.gov/pubmed/26409831
http://dx.doi.org/10.1016/j.radonc.2015.09.009

Ejemplares similares